# FDA Inspection 1238910 - Biomat USA, Inc - May 09, 2024

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/effebdf5-ea41-437d-baaa-1542314115ed
Source feed: FDA_Inspections

> FDA Inspection 1238910 for Biomat USA, Inc on May 09, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238910
- Company Name: Biomat USA, Inc
- Inspection Date: 2024-05-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1028287 - 2017-09-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d12a1f09-675b-4259-98f0-3b5a78e77e3d)
- [FDA Inspection 939452 - 2015-07-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/165fe8d2-922a-454b-a8e3-c682eab5359d)
- [FDA Inspection 865385 - 2014-02-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8c512d6d-512a-45b6-8c1e-508fcc1a0f77)
- [FDA Inspection 761710 - 2012-01-05](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ebd34fe4-7164-4880-a306-54960dbfa354)

Company: https://www.keypedia.com/companies/biomat-usa-inc/633de6c9-af96-4564-ad01-1a2f51b085e0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d